Pricing Log in Create free account

Kairos Pharma, Ltd. (KAPA) vs Notable Labs, Ltd. (NTBLQ)

Kairos Pharma, Ltd. and Notable Labs, Ltd. are both Biotechnology companies. Kairos Pharma, Ltd. and Notable Labs, Ltd. are of similar size ($2.4M and $2.3M). Notable Labs, Ltd. has the higher net margin (6,350.6% vs 0.00%) and the higher return on invested capital (−295.4% vs −322.9%). Across the 13 metrics below, Notable Labs, Ltd. leads on 10 and Kairos Pharma, Ltd. on 3.

Valuation

Metric KAPA NTBLQ Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.44 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.14 0.25 0.64
EV/Sales n/m 23.30 9.21
Earnings yield (326.58%) 0.00% (33.15%)
Free cash flow yield (216.16%) 0.00% (25.50%)

Profitability

Metric KAPA NTBLQ Biotechnology median
Gross margin — 116.87% 65.16%
Operating margin 0.00% 9,259.04% 0.00%
Net margin 0.00% 6,350.60% 0.00%
Free cash flow margin 0.00% 9,158.43% 0.00%
Return on equity (113.96%) (79.79%) (56.36%)
Return on assets (104.32%) (59.14%) (48.04%)
Return on invested capital (322.91%) (295.36%) 0.00%

Growth

Metric KAPA NTBLQ Biotechnology median
Revenue growth (TTM) — (129.02%) 6.02%
EPS growth (last fiscal year) (30.44%) 84.47% 30.26%
Revenue growth, 5-year CAGR — (11.93%) 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KAPA NTBLQ Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 11.98 2.77 4.72
Net debt to EBITDA 1.65 0.80 0.96

Dividend

Metric KAPA NTBLQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KAPA NTBLQ Biotechnology median
Market cap 2.27m 2.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack